David Lustig

David Lustig is an experienced executive in the life sciences sector, currently serving as Vice President of Business Development at Evotec since 2012. With a comprehensive background in drug discovery, development, and manufacturing, David has held significant roles at various organizations, including Aragen Bioscience and Abzena, where leadership in sales and marketing was pivotal. David also founded and led KDL Software and IDN Inc., achieving notable commercial success. Furthermore, David has been a member of Life Science Angels and has experience in preclinical development at CV Therapeutics. David holds a Ph.D. in Chemistry from the University of Michigan and a BS in Chemistry from Indiana University Bloomington.